Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: PT-141 + Oxytocin evidence and protocol review
Also known as: PT141/Oxytocin
This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.
Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.
PT-141 + Oxytocin combines PT-141 + Oxytocin into a single research protocol. Each component is independently studied; this entry summarizes the individual evidence base for the combination, since no unified safety/efficacy dataset covers the mixed formulation unless noted below. PT-141: Cyclic heptapeptide melanocortin receptor agonist (bremelanotide); FDA-approved as Vyleesi for HSDD in premenopausal women - one of the few research peptides with full FDA approval, acting centrally via MC3R/MC4R. Oxytocin: Endogenous neuropeptide hormone; intranasal formulation studied for prosocial effects (trust, empathy) and social-cognition deficits in autism, though replication of early 'trust hormone' findings has been mixed. This is a community-stacking combination assembled from two independently studied compounds rather than a pharmaceutical sponsor's dedicated fixed-dose combination program - no dedicated human combination trial exists for this exact pairing as of this writing.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Evidence for individual components does not validate the exact mixed formulation. Component amounts, ratios, compatibility, sterility, and stability must be documented.
Supplementary research context only. Not medical advice or a treatment recommendation.
Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.
Community discussion of PT-141 combined with Oxytocin is common in self-directed research circles; users report varied subjective effects on libido/desire and describe combining the two for a broader effect profile, though nausea and flushing are commonly mentioned PT-141 side effects. Anecdotal, not clinically verified for this specific combination.
Community thread with users discussing dosing and combined use of PT-141 and Oxytocin; discussion-oriented, largely anecdotal.
Community discussion of PT-141's subjective libido effects, with mixed reports and commonly mentioned side effects like nausea/flushing.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention PT-141 + Oxytocin or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.